Citadel Advisors
JBIO

Citadel Advisors’s Jade Biosciences JBIO Stock Holding History

Citadel Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93M Buy
137,222
+101,167
+281% +$1.46M ﹤0.01% 6137
2025
Q4 		$556K Buy
+36,055
New +$423K ﹤0.01% 8771
2025
Q2 		– Sell
-899
Closed -$79K – 12502
2025
Q1 		$79K Buy
899
+740
+465% +$65K ﹤0.01% 11780
2024
Q4 		$14.7K Buy
+159
New +$13.7K ﹤0.01% 13394
2023
Q3 		– Sell
-8,341
Closed -$5.01M – 14266
2023
Q2 		$5.01M Buy
+8,341
New +$5.33M ﹤0.01% 3645
2023
Q1 		– Sell
-44,626
Closed -$45.8M – 14688
2022
Q4 		$45.8M Sell
44,626
-1,533
-3% -$1.11M 0.01% 1190
2022
Q3 		$26.8M Buy
46,159
+673
+1% +$449K 0.01% 1597
2022
Q2 		$24.9M Sell
45,486
-39
-0.1% -$18.6K 0.01% 1624
2022
Q1 		$29.2M Sell
45,525
-117
-0.3% -$45.4K 0.01% 1579
2021
Q4 		$18.8M Buy
45,642
+76
+0.2% +$38.4K ﹤0.01% 2099
2021
Q3 		$32.4M Sell
45,566
-577
-1% -$323K 0.01% 1503
2021
Q2 		$35.5M Buy
+46,143
New +$36.9M 0.01% 1434

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return